VTRS FY 2015 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$9.4B+22.1% YoY

Gross Profit

$4.2B44.7% margin

Operating Income

$1.5B15.5% margin

Net Income

$848M9.0% margin

EPS (Diluted)

$1.70

Cash Flow

Operating Cash Flow

$2.0B

Free Cash Flow

$1.6B

Stock-Based Comp.

$93M

Balance Sheet

Total Assets

$22.3B

Total Liabilities

$12.5B

Stockholders' Equity

$9.8B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9.4B	$7.7B	+22.1%
Gross Profit	$4.2B	$3.5B	+19.5%
Operating Income	$1.5B	$1.4B	+8.0%
Net Income	$848M	$929M	-8.8%